Accelerate Your Future
After decades of research and development, antibody-based drugs are now the fastest growing class of therapeutic agents.
It is expected that more antibody-based therapeutics will enter into the market in the future and will have broader clinical applications. This whitepaper identifies four major trends that may help to predict future R&D efforts, for example, an aging global population and corresponding rising cancer incidence present a need for more effective cancer treatment.
Download the whitepaper to explore all four trends identified by the collaboration between Analytics Experts at CAS and National Science Library of The Chinese Academy of Sciences.